Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocugen, Inc. - Common Stock
(NQ:
OCGN
)
2.480
+0.140 (+5.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ocugen, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Keep an eye on the top gainers and losers in Wednesday's session.
↗
March 11, 2026
Via
Chartmill
Top movers in Wednesday's session
↗
March 11, 2026
Via
Chartmill
Ocugen (OCGN) Q4 2025 Earnings Call Transcript
↗
March 04, 2026
Ocugen (OCGN) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Ocugen Inc (NASDAQ:OCGN) Stock Drops 7% on Q4 Revenue Miss, Highlights Clinical Pipeline
↗
March 04, 2026
Via
Chartmill
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Demystifying Ocugen: Insights From 5 Analyst Reviews
↗
August 04, 2025
Via
Benzinga
A Peek at Ocugen's Future Earnings
↗
July 31, 2025
Via
Benzinga
A Look at Ocugen's Upcoming Earnings Report
↗
May 08, 2025
Via
Benzinga
Why Did OCGN Stock Rise Today?
↗
February 25, 2026
Ocugen said that it intends to start seeking the approval of the FDA for its experimental therapy OCU400 starting this year.
Via
Stocktwits
Ocugen Stock Is Surging Today: What's Driving The Action?
↗
January 16, 2026
Ocugen Inc (NASDAQ:OCGN) shares are up on Friday as the company is gaining traction following positive market sentiment.
Via
Benzinga
OCGN Stock Rises Pre-Market After Gene Therapy Data Shows Promise In Rare Eye Disorder
↗
January 12, 2026
Stargardt disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe combined.
Via
Stocktwits
Ocugen (OCGN) Q3 2025 Earnings Call Transcript
↗
November 05, 2025
Ocugen (OCGN) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
OCUGEN INC (NASDAQ:OCGN) Reports Mixed Q3 2025 Results Amid Clinical Pipeline Progress
↗
November 05, 2025
Ocugen reports Q3 2025 results with a major revenue beat and updates on its late-stage gene therapy pipeline for blindness diseases.
Via
Chartmill
Beyond The Numbers: 5 Analysts Discuss Ocugen Stock
↗
March 06, 2025
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Ocugen
↗
September 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 17, 2025
Via
Benzinga
Why Ocugen Stock Zoomed 12% Higher Today
↗
September 15, 2025
A peer across the Pacific Ocean has purchased the rights to one of the biotech's pipeline drugs.
Via
The Motley Fool
Ocugen Shares Are Trading Higher Monday: What's Going On?
↗
September 15, 2025
Ocugen shares are trading higher Monday after the company announced a licensing agreement with Kwangdong Pharmaceutical for the exclusive Korean rights to OCU400.
Via
Benzinga
Ocugen (OCGN) Q2 Revenue Jumps 20%
↗
August 01, 2025
Via
The Motley Fool
Ocugen Inc (NASDAQ:OCGN) Q2 2025 Earnings: Revenue Surges, EPS Loss Narrows
↗
August 01, 2025
Ocugen Inc (OCGN) reports Q2 2025 earnings with $1.37M revenue, beating estimates by 284%, while EPS loss narrows to -$0.05. Progress in gene therapy trials boosts investor optimism.
Via
Chartmill
Earnings Scheduled For August 1, 2025
↗
August 01, 2025
Via
Benzinga
5 Biotech Stocks with Highly Anticipated Pending Results
↗
June 26, 2025
Via
Stocktwits
Topics
Intellectual Property
Ocugen (OCGN) Shares Slide Following Merger Agreement: What's Going On?
↗
June 23, 2025
Shares of Ocugen are trading lower Monday afternoon. The company earlier announced a definitive agreement to merge its subsidiary OrthoCellix with Carisma Therapeutics.
Via
Benzinga
Ocugen (OCGN) Stock Soars On FDA Clearance For Pivotal Stargardt Disease Trial
↗
June 16, 2025
Ocugen's gene therapy for Stargardt disease is now advancing to a pivotal trial. The company's treatment could help patients who currently have no other options.
Via
Benzinga
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
↗
May 12, 2025
Via
Benzinga
The Analyst Verdict: Ocugen In The Eyes Of 5 Experts
↗
May 12, 2025
Via
Benzinga
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish
↗
May 09, 2025
CEO Shankar Musunuri said that the company is “on track” to meet its goal of submitting applications to the FDA requesting approval for the distribution of three of its products in the next three...
Via
Stocktwits
Topics
Lawsuit
Earnings Scheduled For May 9, 2025
↗
May 09, 2025
Via
Benzinga
Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates
↗
March 05, 2025
Watchers on Stocktwits expressed optimism about the company’s pipeline and its aim to secure three BLAs over the next three years.
Via
Stocktwits
Ocugen (OCGN) Q4 2024 Earnings Call Transcript
↗
March 05, 2025
OCGN earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
